ESR1 and neoplasm: Interestingly, about 1/6 to 1/8 of MEC-b belong to the category of the so-called ER low-positive BC, defined by ER expression in < 10% of the tumor cells [44], a feature shared also with other salivary gland-like tumors of the breast [40, 45–47].